Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

79.21 USD +1.14 (+1.46%)
Official Closing Price Updated: 7:50 PM EDT, Oct 22, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,797,777
Open 78.10
Bid (Size) 79.15 (1)
Ask (Size) 79.50 (1)
Prev. Close 78.07
Today's Range 78.10 - 79.45
52wk Range 65.25 - 92.64
Shares Outstanding 2,690,303,898
Dividend Yield 2.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market
Financialnewsmedia.com News Commentary 
From PR Newswire

Performance

YTD
-13.94%
-13.94%
1 Month
-4.50%
-4.50%
3 Month
+1.47%
+1.47%
6 Month
-2.06%
-2.06%
1 Year
-4.42%
-4.42%

More News

Read More
Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts
From Business Wire News Releases
Anti-Infective Drugs Market Research Report 2020 Growth, Recent Trends and Forecast to 2030; Gilead Sciences, Inc. (NASDAQ:GILD); Merck & Co. Inc.(NYSE:MRK)
Tags Industry News Life Sciences Recent Press Releases
From X herald
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment for Patients with Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma
From PR Newswire
Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020
From Business Wire News Releases
MSD Issues 2019/2020 Corporate Responsibility Report
Tags Research, Reports & Publications Sustainability MSD
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Orphan Drugs Market 2020 | Global Industry Overview, Sales Revenue, Demand and Opportunity 2025
Tags Health & Medicine
From AB Newswire
Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
From Business Wire News Releases
SPACs Surge as Biotech Booms
From PR Newswire
Noteworthy ETF Outflows: IVV, PFE, WMT, MRK
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.